Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature

Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature

<p>Dasatinib is a potent tyrosine kinase inhibitor, in disease states associated with BCR/ABL 1, approved in 2006 for chronic myeloid leukemia treatment. This agent has been shown to exhibit broad off-target kinase inhibition and immunomodulating properties. These effects may be responsible fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Graziana Arborea (Author), Anna Maria Valentini (Author), Stefania Marangi (Author), Nicoletta Labarile LT (Author), Maria Teresa Savino (Author)
Format: Book
Published: International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, 2023-05-24.
Subjects:
Case Report
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items